Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Grover

Showing results (41-50 of 295) with videos related to

Pageof 30
Sort By:
European Journal of Pharmacology|November 3, 1987
The effect of diltiazem on ST-segment elevation and myocardial blood flow distribution during pacing-induced ischemiaG J Grover, C S Parham
Cardiovascular Drug Reviews|August 15, 2002
Pharmacologic profile of the selective mitochondrial-K(ATP) opener BMS-191095 for treatment of acute myocardial ischemiaGary J Grover, Karnail S Atwal
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1988
Thromboxane A2 antagonist and diltiazem-induced enhancement of contractile function: the effect of timing of treatmentG J Grover, I E Fulmor
Journal of Cardiovascular Pharmacology|November 1, 1995
Protective effect of K(ATP) openers in ischemic rat hearts treated with a potassium cardioplegic solutionG J Grover, P G Sleph
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1989
Effect of the thromboxane A2 receptor antagonist SQ 30,741 on ultimate myocardial infarct size, reperfusion injury and coronary flow reserveG J Grover, W A Schumacher
Basic Research in Cardiology|January 1, 1989
The effect of the thromboxane A2 receptor antagonist SQ 29,548 on the severity of pacing-induced ischemiaG J Grover, W A Schumacher
Journal of Cardiovascular Pharmacology|January 1, 1988
Effect of the thromboxane receptor antagonist SQ 29,548 on myocardial infarct size in dogsG J Grover, W A Schumacher
Journal of the American College of Cardiology|March 15, 1990
The thromboxane receptor antagonist SQ 30,741 reduces myocardial infarct size in monkeys when given during reperfusion at a threshold dose for improving reflow during thrombolysisW A Schumacher, G J Grover
Journal of Cardiovascular Pharmacology|November 1, 1987
Effect of intracoronary diltiazem on ST-segment elevation and myocardial blood flow during pacing-induced ischemiaG J Grover, C S Parham
Mini Reviews in Medicinal Chemistry|February 3, 2007
Recent advances in the development of agonists selective for beta1-type thyroid hormone receptorJ Malm, G J Grover, M Färnegårdh
Pageof 30

Showing results (41-50 of 295) with videos related to

Sort By:
Pageof 30
European Journal of Pharmacology|November 3, 1987
The effect of diltiazem on ST-segment elevation and myocardial blood flow distribution during pacing-induced ischemiaG J Grover, C S Parham
Cardiovascular Drug Reviews|August 15, 2002
Pharmacologic profile of the selective mitochondrial-K(ATP) opener BMS-191095 for treatment of acute myocardial ischemiaGary J Grover, Karnail S Atwal
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1988
Thromboxane A2 antagonist and diltiazem-induced enhancement of contractile function: the effect of timing of treatmentG J Grover, I E Fulmor
Journal of Cardiovascular Pharmacology|November 1, 1995
Protective effect of K(ATP) openers in ischemic rat hearts treated with a potassium cardioplegic solutionG J Grover, P G Sleph
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1989
Effect of the thromboxane A2 receptor antagonist SQ 30,741 on ultimate myocardial infarct size, reperfusion injury and coronary flow reserveG J Grover, W A Schumacher
Basic Research in Cardiology|January 1, 1989
The effect of the thromboxane A2 receptor antagonist SQ 29,548 on the severity of pacing-induced ischemiaG J Grover, W A Schumacher
Journal of Cardiovascular Pharmacology|January 1, 1988
Effect of the thromboxane receptor antagonist SQ 29,548 on myocardial infarct size in dogsG J Grover, W A Schumacher
Journal of the American College of Cardiology|March 15, 1990
The thromboxane receptor antagonist SQ 30,741 reduces myocardial infarct size in monkeys when given during reperfusion at a threshold dose for improving reflow during thrombolysisW A Schumacher, G J Grover
Journal of Cardiovascular Pharmacology|November 1, 1987
Effect of intracoronary diltiazem on ST-segment elevation and myocardial blood flow during pacing-induced ischemiaG J Grover, C S Parham
Mini Reviews in Medicinal Chemistry|February 3, 2007
Recent advances in the development of agonists selective for beta1-type thyroid hormone receptorJ Malm, G J Grover, M Färnegårdh
Pageof 30